Back to results
US 2026/0272828 A1Published application
Sterile formulation of an anesthetic and bronchodilator
OwnerSteven Warringtoninventor
Life of this patent
Estimating the term…
Abstract
This invention is a sterile formulation of an anesthetic and bronchodilator. It can be used through multiple methods. Some embodiments contain an additional therapeutic agent with the ultimate formulation remaining sterile. Some embodiments are diluted in a sterile solution with the ultimate diluted formulation remaining sterile. Some embodiments are specifically intended for use by delivery to the respiratory, oropharyngeal, and/or nasopharyngeal tract.
Claims20
A sterile formulation that includes
- an effective amount of at least one local anesthetic or a pharmaceutically acceptable salt thereof, and
- an effective amount of at least one anticholinergic bronchodilator or a pharmaceutically acceptable salt thereof.
A sterile formulation that includes
- an effective amount of at least one local anesthetic or a pharmaceutically acceptable salt thereof, and
- an effective amount of at least one short acting beta-2 agonist bronchodilator or a pharmaceutically acceptable salt thereof.
A sterile formulation that includes
- an effective amount of at least one local anesthetic or a pharmaceutically acceptable salt thereof, and
- an effective amount of at least one bronchodilator that is chosen from ipratropium, tiotropium, formoterol, levalbuterol, salbutamol, salmeterol, and/or terbutaline, or a pharmaceutically acceptable salt thereof.
Dependencies are inferred from the claim text.